Trends in paediatric inflammatory bowel disease-attributable direct costs: a population-based analysis.
Wael El-MataryZoann NugentJulia WittCharles N BernsteinPublished in: Alimentary pharmacology & therapeutics (2021)
Over two decades, there was a significant increase in the paediatric IBD-attributable direct costs mainly driven by medication costs.